Researchers at the University of Georgia have created an experimental vaccine that could be effective against multiple types of fungal germs, including those that cause vaginal yeast infections. The vaccine candidate, NXT-2, has shown promise in protecting mice from Candida albicans, a common culprit of yeast infection.
Fungal infections can cause significant misery, particularly among women who are prone to recurring vulvovaginal candidiasis (RVVC). This condition affects over 100 million women worldwide every year and can be incredibly stressful. Traditional treatments for fungal infections often rely on antibiotics, but fungi have developed resistance to these medications.
The new vaccine has the potential to provide a long-term solution by targeting multiple types of fungal germs. While it is still in the early stages, the University of Georgia team hopes that NXT-2 will help protect people who are at high risk for life-threatening infections. The next step would be to test the vaccine in humans with RVVC, which could pave the way for a broader application against other types of fungal infections.
Source: https://gizmodo.com/a-vaccine-for-yeast-infections-could-soon-be-reality-2000617388